Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β-adrenoceptor stimulation in mice

Journal of Physiology

Volumn 588, Issue 23, 2010, Pages 4811-4823

  Koopman, René ^a   Gehrig, Stefan M ^a   Léger, Bertrand ^a   Trieu, Jennifer ^a   Walrand, Stéphane ^b   Murphy, Kate T ^a   Lynch, Gordon S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INRA and University of Auvergne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; CALPAIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORMOTEROL; MESSENGER RNA; MITOCHONDRIAL PROTEIN; MUSCLE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEASOME; PROTEIN KINASE B; S6 KINASE; SUCCINATE DEHYDROGENASE; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; MOUSE; MUSCLE MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CALPAIN; DRUG ADMINISTRATION SCHEDULE; ETHANOLAMINES; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MUSCLE PROTEINS; MUSCLE, SKELETAL; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, ADRENERGIC, BETA; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 78649718441     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.196725     Document Type: Article

References (32)

1. Busquets S, Figueras MT, Fuster G, Almendro V, Moore-Carrasco R, Ametller E, Argilés JM & Lopez-Soriano FJ (2004). Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting. Cancer Res 64, 6725-6731.
2. Chang JC, Lee WC, Wu YT & Tsai TH (2009). Distribution of blood-muscle for clenbuterol in rat using microdialysis. Int J Pharm 372, 91-96.
3. Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P, Wackerhage H, Taylor PM & Rennie MJ (2005). Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J 19, 422-424.
4. De Boer MD, Selby A, Atherton P, Smith K, Seynnes OR, Maganaris CN, Maffulli N, Movin T, Narici MV & Rennie MJ (2007). The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol 585, 241-251.
5. Gehrig SM, Koopman R, Naim T, Tjoakarfa C & Lynch GS (2010). Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Am J Pathol 176, 29-33.
6. Guillet C, Zangarelli A, Mishellany A, Rousset P, Sornet C, Dardevet D & Boirie Y (2004). Mitochondrial and sarcoplasmic proteins, but not myosin heavy chain, are sensitive to leucine supplementation in old rat skeletal muscle. Exp Gerontol 39, 745-751.
7. Harcourt LJ, Schertzer JD, Ryall JG & Lynch GS (2007). Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue. Neuromuscul Disord 17, 47-55.
8. Hobler SC, Williams A, Fischer D, Wang JJ, Sun X, Fischer JE, Monaco JJ & Hasselgren PO (1999). Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis. Am J Physiol Regul Integr Comp Physiol 277, R434-440.
9. Kline WO, Panaro FJ, Yang H & Bodine SC (2007). Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J Appl Physiol 102, 740-747.
10. Koopman R, Manders RJ, Jonkers RA, Hul GB, Kuipers H & Van Loon LJ (2006). Intramyocellular lipid and glycogen content are reduced following resistance exercise in untrained healthy males. Eur J Appl Physiol 96, 525-534.
11. Kumar V, Selby A, Rankin D, Patel R, Atherton P, Hildebrandt W, Williams J, Smith K, Seynnes O, Hiscock N & Rennie MJ (2009). Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J Physiol 587, 211-217.
12. Lynch GS & Ryall JG (2008). Role of β-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. Physiol Rev 88, 729-767.
13. Maltin CA, Hay SM, Delday MI, Lobley GE & Reeds PJ (1989). The action of the β-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles. Biochem J 261, 965-971.
14. Maltin CA, Hay SM, Delday MI, Smith FG, Lobley GE & Reeds PJ (1987). Clenbuterol, a βagonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms. Biosci Rep 7, 525-532.
15. Maltin CA, Hay SM, McMillan DN & Delday MI (1992). Tissue specific responses to clenbuterol; temporal changes in protein metabolism of striated muscle and visceral tissues from rats. Growth Regul 2, 161-166.
16. Minnaard R, Wagenmakers AJ, Combaret L, Attaix D, Drost MR, Van Kranenburg GP, Schaart G & Hesselink MK (2005). Ubiquitin-proteasome-dependent proteolytic activity remains elevated after zymosan-induced sepsis in rats while muscle mass recovers. Int J Biochem Cell Biol 37, 2217-2225.
17. Murphy KT, Koopman R, Naim T, Leger B, Trieu J, Ibebunjo C & Lynch GS (2010). Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J (in press).
18. 2-adrenoceptors and cAMP. Am J Physiol Endocrinol Metab 281, E449-454.
19. Osowska S, Duchemann T, Walrand S, Paillard A, Boirie Y, Cynober L & Moinard C (2006). Citrulline modulates muscle protein metabolism in old malnourished rats. Am J Physiol Endocrinol Metab 291, E582-586.
20. Parr T, Bardsley RG, Gilmour RS & Buttery PJ (1992). Changes in calpain and calpastatin mRNA induced by beta-adrenergic stimulation of bovine skeletal muscle. Eur J Biochem 208, 333-339.
21. Pearen MA, Myers SA, Raichur S, Ryall JG, Lynch GS & Muscat GE (2008). The orphan nuclear receptor, NOR-1, a target of β-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology 149, 2853-2865.
22. Rasmussen BB, Fujita S, Wolfe RR, Mittendorfer B, Roy M, Rowe VL & Volpi E (2006). Insulin resistance of muscle protein metabolism in aging. FASEB J 20, 768-769.
23. Robinson MM, Richards JC, Hickey MS, Moore DR, Phillips SM, Bell C & Miller BF (2010). Acute β-adrenergic stimulation does not alter mitochondrial protein synthesis or markers of mitochondrial biogenesis in adult men. Am J Physiol Regul Integr Comp Physiol 298, R25-33.
24. Rooyackers OE, Adey DB, Ades PA & Nair KS (1996). Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle. Proc Natl Acad Sci U S A 93, 15364-15369.
25. 2-Agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol 555, 175-188.
26. Ryall JG, Schertzer JD & Lynch GS (2007). Attenuation of age-related muscle wasting and weakness in rats after formoterol treatment: therapeutic implications for sarcopenia. J Gerontol A Biol Sci Med Sci 62, 813-823.
27. Ryall JG, Schertzer JD & Lynch GS (2008a). Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9, 213-228.
28. 2+-ATPase protein and activity. Am J Physiol Heart Circ Physiol 294, H2587-2595.
29. 2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Br J Pharmacol 147, 587-595.
30. 2+-activated, and ubiquitin-proteasome proteolytic pathways. J Clin Invest 97, 1610-1617.
31. Wei W, Fareed MU, Evenson A, Menconi MJ, Yang H, Petkova V & Hasselgren PO (2005). Sepsis stimulates calpain activity in skeletal muscle by decreasing calpastatin activity but does not activate caspase-3. Am J Physiol Regul Integr Comp Physiol 288, R580-590.
32. Zangarelli A, Walrand S, Guillet C, Gachon P, Rousset P, Giraudet C, Picard B & Boirie Y (2004). Centrifugation-based isolation of myosin for measurement of its synthesis rate in small muscle samples. Anal Biochem 327, 55-60.